The rise of copyright’s blockbuster initially drove a period of growth for major pharmaceutical companies, however recent changes present a murky picture for investors. Lower-cost versions are eroding revenue, and https://jimisef454638.idblogmaker.com/39942615/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play